GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rock Creek Pharmaceuticals Inc (OTCPK:RCPIQ) » Definitions » Policy Acquisition Expense

Rock Creek Pharmaceuticals (Rock Creek Pharmaceuticals) Policy Acquisition Expense


View and export this data going back to 2015. Start your Free Trial

What is Rock Creek Pharmaceuticals Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Rock Creek Pharmaceuticals (Rock Creek Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
2040 Whitfield Avenue, Suite 300, Sarasota, FL, USA, 34243
Rock Creek Pharmaceuticals Inc is engaged in research, development, and commercialization of therapies for chronic inflammatory disease and neurologic disorders, utilizing its proprietary compounds. The company is focusing its drug development efforts on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its proprietary formulations of its lead compound anatabine citrate. Its objective is to develop, obtain approval for, and commercialize pharmaceutical products utilizing its anatabine-based and related compounds.
Executives
Lee M Canaan director 20101 HOOVER RD, DETROIT MI 48205
Naomi Whittel director C/O STAR SCIENTIFIC, INC., 4470 COX ROAD, SUITE 110, GLEN ALLEN VA 23060
Ralph B Everett director 1299 PENNSYLVANIA AVE NW, 10TH FL, WASHINGTON DC 20004-2400
Richard L Sharp director C/O CIRCUIT CITY STORES, 9950 MAYLAND DRIVE, RICHMOND VA 23233
Marc D Oken director C/O FALFURRIAS CAPITAL PARTNERS, 100 N. TRYON STREET, SUITE 5120, CHARLOTTE NC 28202
Odonnell Kathleen M Tr Irrev Tr 1 Fbo Francis E Odonnell Jr other: former 10% owner
David C Vorhoff director C/O STAR SCIENTIFIC, INC., 801 LIBERTY WAY, CHESTER VA 23836
Christopher G Miller officer: Chief Financial Officer 801 LIBERTY WAY CHESTER VA 23836